Quantcast

Latest Quark Stories

2010-05-04 08:00:00

FREMONT, Calif., May 4 /PRNewswire/ -- Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that data from the Phase I QPI-1002 (I5NP) DGF Study (NCT#00802347) will be presented at the 2010 American Transplant Congress, taking place May 1-5 in San Diego, California.

2010-03-09 08:00:00

DENVER, March 9 /PRNewswire/ -- Virtela, the world's largest independent managed network services company, today announced that Quark Inc. has renewed its contract for global network services with Virtela.

2010-03-01 08:00:00

FREMONT, Calif., March 1 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, announced today the dosing of the first patient in a Phase I study of the investigational neuroprotective agent, QPI-1007.

2010-02-15 08:46:24

Scientists at the Relativistic Heavy Ion Collider (RHIC), a 2.4-mile-circumference particle accelerator at the U.S. Department of Energy's Brookhaven National Laboratory, report the first hints of profound symmetry transformations in the hot soup of quarks, antiquarks, and gluons produced in RHIC's most energetic collisions.

2010-01-05 07:30:00

FREMONT, Calif., Jan. 5 /PRNewswire/ -- Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that the independent Data Safety Monitoring Board ("DSMB") recommended that QPI-1002 (I5NP) continue on to the next phase of clinical testing.

2009-11-29 12:19:03

Force of interaction between magnetic particles grows stronger with increasing distance.

2009-11-02 07:30:00

FREMONT, Calif., Nov. 2 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel RNA interference (RNAi)-based therapeutics, today announced that James D.

2009-08-03 07:30:00

FREMONT, Calif., Aug. 3 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that James D.


Word of the Day
definiens
  • The word or words serving to define another word or expression, as in a dictionary entry.
The word 'definiens' comes from the Latin word 'definire', 'to define'.
Related